NeoGenomics, Inc. (NEO)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
SERVICES-TESTING LABORATORIES
CEO:
Douglas M. Van Oort
Employees:
1,500
12701 COMMONWEALTH DRIVE, SUITE 9, FORT MYERS, FL 33913
9419231949

NeoGenomics, Inc. operates a network of cancer focused testing laboratories to provide genetic and molecular testing services. The company offers various testing services, including Cytogenetics, Fluorescence In-Situ Hybridization, Flow Cytometry, Immunohistochemistry, Hematopathology, Hereditary Cancer, Molecular Oncology and Pathology. The company operates through one segment: Laboratory Testing Segment. The Laboratory Testing segment delivers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.

Data derived from most recent annual or quarterly report
Market Cap 1.208 Billion Shares Outstanding124.026 Million Avg 30-day Volume 2.484 Million
P/E Ratio1442.7107 Dividend Yield0.0 EPS
Price to Revenue13.5426 Debt to Equity0.2421 EBITDA34.607 Million
Price to Book Value8.6692 Operating Margin-3.1482 Enterprise Value5.861 Billion
Current Ratio6.132 EPS Growth0 Quick Ratio5.508
1 Yr BETA 1.6606 52-week High/Low 54.74 / 7.26 Profit Margin0.9387
Operating Cash Flow Growth-93.7524 Altman Z-Score13.1588 Free Cash Flow to Firm -29.3 Million
Earnings Report2022-08-04
View SEC Filings from NEO instead.

View recent insider trading info

NeoGenomics, Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding NEO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NEO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

5.7 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BONELLO WILLIAM CHIEF FINANCIAL OFFICER

  • Officer
 439,990 2022-04-28 7

BROWN DOUGLAS MATTHEW CHIEF STRATEGY OFFICER

  • Officer
 315,598 2022-04-01 4

SHOLEHVAR DAVID PRESIDENT, CLINICAL SERVICES

  • Officer
 97,236 2022-04-01 2

CARDOZA GEORGE PRESIDENT & COO, LAB OPS

  • Officer
 927,553 2022-03-01 4

GILBERT HALLEY E CHIEF LEGAL OFFICER

  • Officer
 313,350 2022-03-01 5

MALLON MARK CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 866,844 2022-03-01 3

DIETER CYNTHIA J CHIEF ACCOUNTING OFFICER

  • Officer
 71,218 2022-03-01 3

WALLAR GINA M PRESIDENT, PHARMA SERVICES

  • Officer
 110,703 2022-03-01 5

MCKENZIE KATHRYN B CHIEF SUSTAINABILITY/RISK OFCR

  • Officer
 193,840 2022-01-11 3

BALLIET JENNIFER VP AND CHIEF CULTURE OFFICER

  • Officer
 136,052 2021-12-30 2

MORRIS CLIVE PRESIDENT OF INIVATA

  • Officer
 95,137 2021-12-30 3

JOHNSON KEVIN C

  • Director
 48,829 2021-12-22 2

DALY DAVID

  • Director
 0 2021-11-10 2

TETRAULT LYNN A.

  • Director
 50,888 2021-10-11 3

VAN OORT DOUGLAS M

  • Director
 3,440,448 2021-08-01 1

CROWTHER BRUCE K

  • Director
 53,278 2021-06-08 2

HANNAH ALISON L.

  • Director
 106,325 2021-06-02 1

STAHLER RACHEL A

  • Director
 12,941 2021-06-02 1

KANOVSKY STEPHEN M

  • Director
 20,629 2021-06-02 1

KELLY MICHAEL AARON

  • Director
 10,800 2021-06-02 1

SHOVLIN ROBERT J. PRESIDENT, CLINICAL SERVICES

  • Officer
 264,442 2021-05-25 1

WEISS LAWRENCE MARTIN CHIEF MEDICAL OFFICER

  • Officer
 215,224 2021-04-22 0

PEDULLA DENISE E GENERAL COUNSEL

  • Officer
 194,849 2021-03-01 0

JONES STEVEN C

  • Director
 1,386,451 2021-01-07 0

HIPP RAYMOND R

  • Director
 66,800 2020-11-16 0

VIRAG SHARON CHIEF FINANCIAL OFFICER

  • Officer
 10,944 2019-03-01 0

GENERAL ELECTRIC CO

GE MEDICAL SYSTEMS INFORMATION TECHNOLOGIES, INC.

  • FORMER 10% OWNERFORMER 10% OWNER
 No longer subject to file 2018-12-14 0

BRODIE STEVEN G. VP - PHARMA OPERATIONS

  • Officer
 45,953 2018-10-22 0

ROSS STEVEN A CIO

  • Officer
 9,000 2018-05-10 0

BYWATER STEPHANIE K CHIEF COMPLIANCE OFFICER

  • Officer
 528 2018-05-01 0

ROBISON WILLIAM J

  • Director
 359,474 2017-05-25 0

ALBITAR MAHER CHIEF MEDICAL OFFICER

  • Officer
 60,692 2017-04-28 0

MURPHY KIERAN PIUS

  • Director
 0 2016-02-17 0

MACHULCZ MARK ALAN VICE PRESIDENT OF OPERATIONS

  • Officer
 0 2016-01-28 0

HOREL ROBERT H. VICE PRESIDENT GM PATHLOGIC

  • Officer
 51,218 2015-12-29 0

JONES STEVEN C EXECUTIVE VP OF FINANCE

ASPEN SELECT HEALTHCARE LP

  • Officer
  • 10% Owner
 3,886,629 2015-11-25 0

DENT MICHAEL T

  • Director
 1,821,650 2014-12-04 0

GASPARINI ROBERT P CHIEF SCIENCE OFFICER

  • Officer
 8,439 2014-05-22 0

KINDERHOOK, LP

KINDERHOOK GP LLC

KINDERHOOK PARTNERS, LLC

SHAH TUSHAR

CLEARMAN STEPHEN J

  • SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS
 No longer subject to file 2013-05-13 0

SMITS MARK W CHIEF COMMERCIAL OFFICER

  • Officer
 6,667 2011-05-18 0

PETERSON PETER M

  • Director
  • 10% Owner
 8,191,550 2011-05-02 0

MILLER MARYDAWN VICE PRESIDENT OF IT

  • Officer
 0 2011-05-02 0

DVONCH JEROME J PRINICPAL ACCOUNTING OFFICER

  • Officer
 0 2011-05-02 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

BONELLO WILLIAM - Officer CHIEF FINANCIAL OFFICER

2022-05-02 17:46:18 -0400 2022-04-28 M 5,727 d 0 direct

BONELLO WILLIAM - Officer CHIEF FINANCIAL OFFICER

2022-05-02 17:46:18 -0400 2022-04-28 M 5,727 $7.52 a 191,548 direct 3.2487 -20.7107 3.2487 2 -20.7107 6

BONELLO WILLIAM - Officer CHIEF FINANCIAL OFFICER

2022-04-04 19:08:00 -0400 2022-04-01 A 82,305 a 185,821 direct -4.8841 7.4503 15.6457 3 -4.8841 2

BROWN DOUGLAS MATTHEW - Officer CHIEF STRATEGY OFFICER

2022-04-04 19:07:12 -0400 2022-04-01 A 82,305 a 158,684 direct -4.8841 7.4503 15.6457 3 -4.8841 2

SHOLEHVAR DAVID - Officer PRESIDENT, CLINICAL SERVICES

2022-04-04 19:07:32 -0400 2022-04-01 A 66,372 a 66,372 direct

SHOLEHVAR DAVID - Officer PRESIDENT, CLINICAL SERVICES

2022-04-04 19:07:32 -0400 2022-04-01 A 30,864 a 30,864 direct -4.8841 7.4503 15.6457 3 -4.8841 2

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
NEOGENOMICS INC NEO 2022-05-16 22:15:03 UTC 0.5354 0.2846 600000
NEOGENOMICS INC NEO 2022-05-16 21:45:04 UTC 0.5348 0.2852 600000
NEOGENOMICS INC NEO 2022-05-16 21:15:03 UTC 0.5348 0.2852 600000
NEOGENOMICS INC NEO 2022-05-16 20:45:03 UTC 0.5126 0.3074 650000
NEOGENOMICS INC NEO 2022-05-16 20:15:03 UTC 0.5126 0.3074 650000
NEOGENOMICS INC NEO 2022-05-16 19:45:04 UTC 0.5126 0.3074 650000
NEOGENOMICS INC NEO 2022-05-16 19:15:03 UTC 0.5126 0.3074 650000
NEOGENOMICS INC NEO 2022-05-16 18:45:03 UTC 0.57 0.25 650000
NEOGENOMICS INC NEO 2022-05-16 18:15:04 UTC 0.57 0.25 650000
NEOGENOMICS INC NEO 2022-05-16 17:45:03 UTC 0.57 0.25 650000
NEOGENOMICS INC NEO 2022-05-16 17:15:04 UTC 0.57 0.25 650000
NEOGENOMICS INC NEO 2022-05-16 16:45:03 UTC 0.57 0.25 650000
NEOGENOMICS INC NEO 2022-05-16 16:15:03 UTC 0.57 0.25 650000
NEOGENOMICS INC NEO 2022-05-16 15:45:03 UTC 0.57 0.25 650000
NEOGENOMICS INC NEO 2022-05-16 15:15:03 UTC 0.57 0.25 650000
NEOGENOMICS INC NEO 2022-05-16 14:45:03 UTC 0.4839 0.3361 650000
NEOGENOMICS INC NEO 2022-05-16 14:15:03 UTC 0.4839 0.3361 650000
NEOGENOMICS INC NEO 2022-05-16 13:45:04 UTC 0.4839 0.3361 650000
NEOGENOMICS INC NEO 2022-05-16 13:15:03 UTC 0.4839 0.3361 650000
NEOGENOMICS INC NEO 2022-05-16 12:45:04 UTC 0.4839 0.3361 650000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Master Neutral Fund NEO -97.0 shares, $-3578.33 2020-09-30 N-PORT
RUSSELL INVESTMENT CO- U.S. Dynamic Equity Fund NEO -5237.0 shares, $-277665.74 2021-01-31 N-PORT
Prudential Investment Portfolios 12- PGIM QMA Large-Cap Core Equity Plus Fund NEO -2100.0 shares, $-94857.0 2021-06-30 N-PORT
SCHWAB CAPITAL TRUST- Schwab Hedged Equity Fund NEO -3377.0 shares, $-155679.7 2021-07-31 N-PORT
Advanced Series Trust- AST QMA U.S. Equity Alpha Portfolio NEO -42400.0 shares, $-2045376.0 2021-09-30 N-PORT
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund NEO -5202.0 shares, $-177492.24 2021-12-31 N-PORT
Federated Hermes Adviser Series- Federated Hermes MDT Market Neutral Fund NEO -2998.0 shares, $-102291.76 2021-12-31 N-PORT
FundVantage Trust- Gotham Hedged Plus Fund NEO -686.0 shares, $-23406.32 2021-12-31 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund NEO -4900.0 shares, $-167188.0 2021-12-31 N-PORT
Calamos Investment Trust/IL- Calamos Market Neutral Income Fund NEO -71233.0 shares, $-1605591.82 2022-01-31 N-PORT
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund NEO -27708.0 shares, $-624538.32 2022-01-31 N-PORT

Elevate your investments